Olema Pharmaceuticals, Inc.
News
Candriam S.C.A. Purchases 705,655 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
Ticker Report Candriam S.C.A. boosted its position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 199.9% during the second quarter, according to its most recent disclosure with the Securities and...\n more…
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ( Olema or Olema Oncology , Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...\n more…
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth
Simply Wall St There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...\n more…
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 4%
Ticker Report Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) traded down 4% during mid-day trading on Thursday . The stock traded as low as $11.74 and last traded at $11.90. 216,517 shares...\n more…
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 3.7%
Ticker Report Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report)'s stock price shot up 3.7% on Friday . The stock traded as high as $12.08 and last traded at $11.96. 25,616 shares traded hands during...\n more…